Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedAdded the Hepatocellular carcinoma tag, added a resource link to the Genetic and Rare Diseases Information Center, and updated the site revision from 3.4.3 to 3.5.0.SummaryDifference0.2%

- Check27 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No user-facing content changes are evident.SummaryDifference0.1%

- Check55 days agoChange DetectedDeleted notices include a government funding status warning and the prior site revision note (v3.4.1); a new site revision (v3.4.2) has been added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded a site-wide funding/status notice and the page revision tag v3.4.1, and removed the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange DetectedThe page now shows a glossary toggle and new metadata lines (Last Update Submitted that Met QC Criteria; Revision: v3.4.0; No FEAR Act Data). The older QC criterion line and the previous No FEAR Act data wording were removed or changed.SummaryDifference0.2%

- Check83 days agoChange DetectedPage revision label updated from v3.3.3 to v3.3.4; no changes to study content are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.